Public Profile

Hassan Aliashrafzadeh

[Available for Review]

H-index: 3

Manuscripts in Review: 0

Reviewed Articles: 1

Invitation Reply Cycle: 12 h

Total Points: 10

Manuscript Review Cycle: 2 days

Country: United States

Institution: university of california,Davis

Section: Neurosciences

Keywords: kinase inhibitors/minicolumns/traumatic brain injury/fragile X syndrome/interneurons/Angelman syndrome/drug resistance

Representative Publications

Nobiletin in Cancer Therapy; Mechanisms and Therapy Perspectives

Resveratrol as an antitumor agent for glioblastoma multiforme: Targeting resistance and promoting apoptotic cell deaths

Experimental and clinical tests of FDA-approved kinase inhibitors for the treatment of neurological disorders (update 2024)

Review journals:

Exploration of Drug Science (1)   

 A dash (--) means information awaiting reviewer update.

Reviewers you may be interested in

Feeling limited by your filters? Break free and rediscover!

All Reviewers